← Eichor
Condition: Arbovirus Infections Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Arbovirus Infections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean
Phase N/A · 1 location(s) · University Hospital Center of Martinique · NCT04839757Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Phase 3 · 5 location(s) · Butantan Institute · NCT06891950Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue
Phase N/A · 7 location(s) · Takeda · NCT06843226Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Compl
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire de la Réunion · NCT06928753A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)
Phase 2/Phase 3 · 2 location(s) · Hyundai Bioscience Co., Ltd. · NCT07576868Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
Phase N/A · 1 location(s) · Jose Ivan Rodriguez de Molina Serrano · NCT07007585Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Phase 2 · 1 location(s) · U.S. Army Medical Research and Development Command · NCT03609398International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)
Phase N/A · 1 location(s) · Mahidol University · NCT07409857Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes
NA · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT06981442Dengvaxia US Pregnancy Registry
Phase N/A · 1 location(s) · Sanofi Pasteur, a Sanofi Company · NCT04486638Impact of IIT-SIT on Dengue Clusters
NA · 1 location(s) · National Environment Agency, Singapore · NCT06894901Dexamethasone in Tick-borne Encephalitis
Phase 3 · 1 location(s) · University Medical Centre Ljubljana · NCT07584525Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07191223A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Phase 3 · 15 location(s) · Bavarian Nordic · NCT07003984A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
Phase 2 · 24 location(s) · Novartis Pharmaceuticals · NCT06006559A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
Phase 3 · 7 location(s) · Takeda · NCT06579755A Controlled Human Infection Model of Dengue
NA · 1 location(s) · Tan Tock Seng Hospital · NCT07412483Real-World Study on Chinese Medicine for Treating Chikungunya Fever
Phase N/A · 1 location(s) · Guangzhou University of Traditional Chinese Medicine · NCT07120724An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolesce
Phase 3 · 3 location(s) · Bavarian Nordic · NCT07467707High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
Phase 2 · 1 location(s) · Gili Regev-Yochay MD · NCT07094724Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)
NA · 2 location(s) · Chulalongkorn University · NCT05631405A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population
Phase 3 · 13 location(s) · Sanofi · NCT07103148A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid
Phase 1/Phase 2 · 3 location(s) · SK Bioscience Co., Ltd. · NCT06680128Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic
Phase N/A · 4 location(s) · Charles University, Czech Republic · NCT07274046Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients
Phase 2/Phase 3 · 1 location(s) · Phramongkutklao College of Medicine and Hospital · NCT06747130Tick-borne Encephalitis and Borrelial Antibodies in Serum
NA · 1 location(s) · University Medical Centre Ljubljana · NCT03956446Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
Phase 1/Phase 2 · 1 location(s) · Oregon Health and Science University · NCT05859490Adaptive Dengue Antiviral Platform Trial
Phase 2 · 2 location(s) · Oxford University Clinical Research Unit, Vietnam · NCT06551844Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus
Phase N/A · 1 location(s) · IRCCS Sacro Cuore Don Calabria di Negrar · NCT06776692
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.